Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets Life Science Investing News
Outlook Therapeutics Provides Business Update and Reports Financial Results for Fiscal Year 2018 Life Science Investing News
BELLUS Health Closes $35M Financing to Support Development of its Lead Drug Candidate BLU-5937 for Chronic Cough Pharmaceutical Investing
Medexus Announces New Chief Executive Officer, Chair of the Board of Directors, Other Organizational Updates and Equity Incentive Grants Pharmaceutical Investing
U.S. Patent Office Awards Diffusion Exclusive Rights for Use of TSC in Conjunction with Only FDA-Approved Stroke Therapeutic Life Science Investing News
